CLNNW:NSD-Clene Inc (USD)

COMMON STOCK | Packaged Foods |

Last Closing

USD 0.0498

Change

+0.02 (+52.76)%

Market Cap

USD 0.65B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Packaged Foods

Symbol Name Price(Change) Market Cap
KHC Kraft Heinz Co

-1.07 (-3.07%)

USD 43.09B
PPC Pilgrims Pride Corp

-0.40 (-0.83%)

USD 10.87B
FRPT Freshpet Inc

-0.05 (-0.04%)

USD 6.51B
LANC Lancaster Colony Corporation

+2.12 (+1.16%)

USD 4.84B
SMPL Simply Good Foods Co

+0.17 (+0.50%)

USD 3.35B
JJSF J & J Snack Foods Corp

-0.14 (-0.08%)

USD 3.26B
CENTA Central Garden & Pet Company A

-0.45 (-1.51%)

USD 2.01B
CENT Central Garden & Pet Company

-0.44 (-1.27%)

USD 2.00B
JBSS John B Sanfilippo & Son Inc

-0.87 (-0.94%)

USD 1.08B
HAIN The Hain Celestial Group Inc

-0.19 (-2.13%)

USD 0.75B

ETFs Containing CLNNW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Packaged Foods) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.01% 51% F 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.01% 51% F 66% D+
Trailing 12 Months  
Capital Gain -0.60% 39% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.60% 39% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -43.38% 7% C- 2% F
Dividend Return -43.38% 7% C- 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.22% 66% D+ 56% F
Risk Adjusted Return -130.59% 5% F 1% F
Market Capitalization 0.65B 74% C 66% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector